Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Live cell encapsulation industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Polymer type trends
2.1.4 Method trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Live Cell Encapsulation Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing public-private investments to support product development
3.2.1.2 Rising prevalence of target diseases
3.2.1.3 Growing awareness among population pertaining the role of encapsulated cell in disease management
3.2.1.4 Increasing adoption of live cell encapsulation in regenerative medicine and therapeutic purposes
3.2.2 Industry pitfalls & challenges
3.2.2.1 High product manufacturing costs
3.2.2.2 Limited availability of good quality raw material
3.3 Growth potential analysis
3.3.1 By polymer type
3.3.2 By method
3.3.3 By application
3.4 COVID- 19 impact analysis
3.5 Methods and materials used in cell encapsulation
3.6 Cell encapsulated formulations for therapeutic applications
3.6.1 Microencapsulated microorganism formulations for therapeutic applications
3.6.2 Microencapsulated Mammalian Cell Formulations for Therapeutic Applications
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategic outlook matrix
Chapter 5 Live Cell Encapsulation Market Size and Forecast, By Polymer Type (USD Million)
5.1 Key trends, by polymer type
5.2 Natural Polymers
5.2.1 Alginate
5.2.2 Chitosan
5.2.3 Cellulose
5.2.4 Others
5.3 Synthetic Polymers
Chapter 6 Live Cell Encapsulation Market Size and Forecast, By Method (USD Million)
6.1 Key trends, by method
6.2 Microencapsulation
6.3 Macroencapsulation
6.4 Nanoencapsulation
Chapter 7 Live Cell Encapsulation Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Drug Delivery
7.3 Regenerative Medicine
7.4 Cell Transplantation
7.5 Other Applications
Chapter 8 Live Cell Encapsulation Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 Netherlands
8.3.9 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Thailand
8.4.7 Indonesia
8.4.8 Vietnam
8.4.9 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Columbia
8.5.5 Chile
8.5.6 Peru
8.5.7 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Rest of MEA
Chapter 9 Company Profiles
9.1 Austrianova
9.2 Merck KGaA
9.3 Sphere Fluidics Limited
9.4 Blacktrace Holdings Ltd.
9.5 BIO INX
9.6 Isogen
9.7 Diatranz Otsuka Ltd
9.8 PharmaCyte Biotech, Inc.
9.9 Atelerix Ltd.
9.10 Neurotech Pharmaceuticals, Inc.
9.11 Buchi Labortechnik AG
